|
US4838925A
(en)
|
1986-04-25 |
1989-06-13 |
E. I. Du Pont De Nemours And Company |
Heterocyclic acyl sulfonamides
|
|
JP3763997B2
(ja)
|
1999-05-13 |
2006-04-05 |
富士写真フイルム株式会社 |
感熱記録材料
|
|
JP4331823B2
(ja)
|
1999-05-21 |
2009-09-16 |
富士フイルム株式会社 |
ピロロ［１，２−ａ］−１，３，５−トリアジン−４−オン系化合物
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
JP4070966B2
(ja)
|
2001-06-28 |
2008-04-02 |
株式会社カネボウ化粧品 |
新規ガラクトシルセラミド類縁体及び用途
|
|
CA2461159A1
(en)
|
2001-10-22 |
2003-05-01 |
Pfizer Inc. |
Imidazopyridine compounds as 5-ht4 receptor modulators
|
|
AU2003211424A1
(en)
|
2002-03-01 |
2003-09-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound
|
|
CA2499494A1
(en)
|
2002-09-20 |
2004-04-01 |
Pfizer Inc. |
N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators
|
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
|
AU2003299651A1
(en)
|
2002-12-11 |
2004-06-30 |
Merck And Co., Inc. |
Tyrosine kinase inhibitors
|
|
JP2004277337A
(ja)
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
EP1620435A1
(en)
|
2003-04-21 |
2006-02-01 |
Pfizer Inc. |
IMADAZOPYRIDINE COMPOUNDS HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY AND 5-HT sb 3 /sb RECEPTOR ANTAGONISTIC ACTIVITY
|
|
BRPI0416216A
(pt)
|
2003-11-12 |
2006-12-26 |
Amicus Therapeutics Inc |
composto de glicoimidazol e polihidroxiciclohexenila e método para sintetizar composto de glicoimidazol e polihidroxiciclohexenila, métodos para inibir glicocerebrosidase, para aumentar a atividade de glicocerebrosidase e para estabilizar glicocerebrosidade, composição farmacêutica, métodos para inibir uma -glicosidade, e para tratar doença de gaucher, derivado de glicoimidazol e derivados de polihidroxiciclohexilamina
|
|
GB0329214D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
US7645756B2
(en)
|
2004-02-18 |
2010-01-12 |
Banyu Pharmaceutical Co. Ltd. |
Nitrogenous fused heteroaromatic ring derivative
|
|
EP1753422B1
(en)
|
2004-05-14 |
2008-05-28 |
The Cleveland Clinic Foundation |
Small molecule inhibitors for mrp1 and other multidrug transporters
|
|
MXPA06014809A
(es)
|
2004-06-21 |
2007-02-12 |
Hoffmann La Roche |
Derivados de pirazol-pirimidina.
|
|
US20080051409A1
(en)
|
2004-08-02 |
2008-02-28 |
Peter Gmeiner |
Indolizine Carboxamides and Aza and Diaza Derivatives Thereof
|
|
DE102004049363A1
(de)
*
|
2004-10-08 |
2006-04-13 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
WO2006078676A2
(en)
|
2005-01-19 |
2006-07-27 |
Merck & Co., Inc. |
Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
WO2006084835A1
(en)
*
|
2005-02-10 |
2006-08-17 |
Ferrer Internacional, S. A. |
N-(3-(imidazo [1,5-a]pyrimidin-4-yl)phenyl]-sulfonamides and n-[3-(imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides and their use as gabaa receptor modulators
|
|
BRPI0607927A2
(pt)
|
2005-02-11 |
2009-10-20 |
Hoffmann La Roche |
derivados de pirazol-pirimidina
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
WO2006115168A1
(ja)
|
2005-04-21 |
2006-11-02 |
Dainippon Sumitomo Pharma Co., Ltd. |
Ｎ－置換フェニルアセトアミド誘導体およびそれを含有する医薬組成物
|
|
JP5079500B2
(ja)
|
2005-04-28 |
2012-11-21 |
協和発酵キリン株式会社 |
２−アミノキナゾリン誘導体
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
CA2624500A1
(en)
|
2005-10-06 |
2007-04-19 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
CA2626742A1
(en)
|
2005-10-21 |
2007-04-26 |
Exelixis, Inc. |
Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
|
|
KR20080074161A
(ko)
|
2005-12-08 |
2008-08-12 |
노파르티스 아게 |
ＥＰＨＢ 및 ＶＥＧＦＲ２ 키나아제 억제제로서의피라졸로[１,５-ａ]피리딘-３-카르복실산
|
|
TW200800997A
(en)
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
JP5303458B2
(ja)
|
2006-06-23 |
2013-10-02 |
アミークス セラピューティックス インコーポレイテッド |
β−グルコセレブロシダーゼの活性増強による神経学的疾患の治療方法
|
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
|
WO2008019363A2
(en)
|
2006-08-07 |
2008-02-14 |
Albany Molecular Research, Inc. |
2-alkylbenzoxazole carboxamides as 5ht3 modulators
|
|
WO2008063670A1
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic matrix metalloprotease inhibitors
|
|
US20080176870A1
(en)
|
2006-11-20 |
2008-07-24 |
Bert Nolte |
Heterobicyclic metalloprotease inhibitors
|
|
US20080255153A1
(en)
|
2007-03-28 |
2008-10-16 |
Biovitrum Ab (Publ) |
New compounds
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
EA201000003A1
(ru)
|
2007-06-21 |
2010-06-30 |
Айрм Ллк |
Ингибиторы протеинкиназ и способы их применения
|
|
WO2009060835A1
(ja)
|
2007-11-05 |
2009-05-14 |
Kyoto University |
新規ユビキリン結合性小分子
|
|
US20110046127A1
(en)
|
2007-11-08 |
2011-02-24 |
Paolo Pevarello |
Imidazopyridazines for Use as Protein Kinase Inhibitors
|
|
CA2706946A1
(en)
|
2007-11-28 |
2009-06-04 |
Schering Corporation |
2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
US8389527B2
(en)
|
2008-02-06 |
2013-03-05 |
Bristol-Myers Squibb Company |
Substituted imidazopyridazines useful as kinase inhibitors
|
|
JPWO2009119088A1
(ja)
|
2008-03-25 |
2011-07-21 |
武田薬品工業株式会社 |
複素環化合物
|
|
CA2723135A1
(en)
|
2008-05-01 |
2009-11-05 |
Sirtris Pharmaceuticals, Inc. |
Quenolines and related analogs as sirtuin modulators
|
|
UY32174A
(es)
|
2008-10-14 |
2010-05-31 |
Astrazeneca Ab |
Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
|
|
BRPI0914404A2
(pt)
|
2008-10-31 |
2019-03-06 |
Genentech Inc |
"compostos, composição farmacêutica e método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak quinase em um paciente"
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
KR101721280B1
(ko)
|
2009-08-17 |
2017-03-29 |
인텔리카인, 엘엘씨 |
헤테로사이클릭 화합물 및 이의 용도
|
|
MX340490B
(es)
|
2010-07-13 |
2016-07-11 |
F Hoffmann-La Roche Ag * |
Derivados de pirazolo [1, 5a] pirimidina y de tieno [3, 2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
TW201217312A
(en)
|
2010-09-22 |
2012-05-01 |
Gruenenthal Gmbh |
Substituted benzamide compounds
|
|
WO2012075393A2
(en)
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
|
SI3366688T1
(sl)
*
|
2010-12-08 |
2022-07-29 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Substituirani pirazolopirimidini kot aktivatorji glukocerebrozidaze
|
|
US9127000B2
(en)
|
2011-02-23 |
2015-09-08 |
Intellikine, LLC. |
Heterocyclic compounds and uses thereof
|
|
WO2012129258A1
(en)
|
2011-03-22 |
2012-09-27 |
Merck Sharp & Dohme Corp. |
Amidopyrazole inhibitors of interleukin receptor-associated kinases
|
|
WO2012177997A1
(en)
|
2011-06-22 |
2012-12-27 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
US9216968B2
(en)
|
2011-08-18 |
2015-12-22 |
Nippon Shinyaku Co., Ltd. |
Heterocyclic derivative and pharmaceutical drug
|
|
WO2013030288A1
(de)
|
2011-09-02 |
2013-03-07 |
Bayer Intellectual Property Gmbh |
Substituierte annellierte pyrimidine und ihre verwendung
|
|
WO2013059119A1
(en)
|
2011-10-17 |
2013-04-25 |
The Regents Of The University Of Michigan |
Glucosylceramide synthase inhibitors and therapeutic methods using the same
|
|
US9957271B2
(en)
|
2011-10-20 |
2018-05-01 |
Glaxosmithkline Llc |
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
|
|
JP2015503519A
(ja)
|
2011-12-23 |
2015-02-02 |
ノバルティス アーゲー |
Ｂｃｌ２と結合相手の相互作用を阻害するための化合物
|
|
WO2013134079A1
(en)
|
2012-03-05 |
2013-09-12 |
Amgen Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
US8969565B2
(en)
|
2012-03-09 |
2015-03-03 |
Lexicon Pharmaceuticals, Inc. |
Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use
|
|
PL2822555T3
(pl)
|
2012-03-09 |
2018-04-30 |
Lexicon Pharmaceuticals Inc |
Inhibicja związanej z adaptorem kinazy-1 dla leczenia bólu
|
|
AU2013240187A1
(en)
|
2012-03-28 |
2014-10-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Salicylic acid derivatives useful as glucocerebrosidase activators
|
|
WO2013178591A1
(en)
|
2012-05-31 |
2013-12-05 |
F. Hoffmann-La Roche Ag |
Aminoquinazoline and pyridopyrimidine derivatives
|
|
EP2865671B1
(en)
|
2012-06-22 |
2017-11-01 |
Sumitomo Chemical Company, Ltd |
Fused heterocyclic compound
|
|
WO2014025651A1
(en)
|
2012-08-06 |
2014-02-13 |
Amgen Inc. |
Chroman derivatives as trpm8 inhibitors
|
|
BR112015004858A2
(pt)
|
2012-09-05 |
2017-07-04 |
Bayer Cropscience Ag |
uso de 2-amidobenzimidazóis, 2-amidobenzoxazóis e 2-amidobenzotiazóis substituídos ou sais dos mesmos como substâncias ativas contra estresse abiótico em plantas
|
|
AU2013344716B2
(en)
|
2012-11-16 |
2018-03-01 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
US9938258B2
(en)
|
2012-11-29 |
2018-04-10 |
Karyopharm Therapeutics Inc. |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
|
|
TR201807740T4
(tr)
|
2012-12-07 |
2018-06-21 |
Vertex Pharma |
ATR kinaz inhibitörü olarak 2-amino-6-fluoro-n-(5-fluoro-4-(4-(4-(oksetan-3-il)piperazin-1-karbonil)piperidin-1-il)piridin-3-il)pirazolo[1,5alfa]pirimidin-3-karboksamid.
|
|
KR20140086002A
(ko)
|
2012-12-28 |
2014-07-08 |
한미약품 주식회사 |
Fms 키나아제 저해 활성을 갖는 피리다진 접합고리 유도체
|
|
WO2014141129A2
(en)
|
2013-03-14 |
2014-09-18 |
Grueneberg Dorre A |
Novel methods, compounds, and compositions for inhibition of ros
|
|
WO2014144455A1
(en)
|
2013-03-15 |
2014-09-18 |
Epizyme, Inc. |
1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
WO2015012328A1
(ja)
|
2013-07-24 |
2015-01-29 |
武田薬品工業株式会社 |
複素環化合物
|
|
EP3035921A1
(en)
|
2013-08-20 |
2016-06-29 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
|
CR20160135A
(es)
|
2013-08-23 |
2016-08-05 |
Incyte Corp |
Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de cinasas pim
|
|
AR097543A1
(es)
|
2013-09-06 |
2016-03-23 |
Lexicon Pharmaceuticals Inc |
COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
|
|
TW201542550A
(zh)
|
2013-09-06 |
2015-11-16 |
Lexicon Pharmaceuticals Inc |
吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
|
|
WO2015073267A1
(en)
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
ES2687843T3
(es)
|
2014-03-27 |
2018-10-29 |
Academisch Medisch Centrum |
Iminoazúcares N-(5-((aril o heteroril)metiloxi)pentil)-sustituidos como inhibidores de glucosilceramida sintasa
|
|
WO2016007736A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines as lsd1 inhibitors
|
|
ES2958391T3
(es)
|
2014-11-06 |
2024-02-08 |
Bial R&D Invest S A |
Imidazo[1,5-a]pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos
|
|
EP3215509B1
(en)
|
2014-11-06 |
2020-02-26 |
Lysosomal Therapeutics Inc. |
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
|
|
SMT202400187T1
(it)
|
2014-11-06 |
2024-07-09 |
Bial R&D Investments S A |
Pirazolo(1,5-a)pirimidine sostituite e loro utilizzo nel trattamento di disturbi medici
|
|
WO2017004405A1
(en)
|
2015-07-01 |
2017-01-05 |
Northwestern University |
Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity
|
|
CN108290894A
(zh)
*
|
2015-07-01 |
2018-07-17 |
西北大学 |
被取代的4-甲基-吡咯并[1,2-a]嘧啶-8-甲酰胺类化合物及其调节葡糖脑苷脂酶活性的用途
|
|
WO2017040877A1
(en)
|
2015-09-04 |
2017-03-09 |
Lysosomal Therapeutics Inc. |
Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
|
|
US10065963B2
(en)
|
2015-11-06 |
2018-09-04 |
Incyte Corporation |
Heterocyclic compounds as PI3K-γ inhibitors
|
|
JP6843135B2
(ja)
|
2015-11-18 |
2021-03-17 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ＩＬ−１２、ＩＬ−２３および／またはＩＦＮα応答のモジュレーターとして有用なイミダゾピリダジン化合物
|
|
EP3416967B1
(en)
|
2016-02-18 |
2022-02-09 |
F. Hoffmann-La Roche AG |
Therapeutic compounds, compositions and methods of use thereof
|
|
AU2017246455B2
(en)
|
2016-04-06 |
2021-09-30 |
Bial - R&D Investments, S.A. |
Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
WO2017176962A1
(en)
|
2016-04-06 |
2017-10-12 |
Lysosomal Therapeutics, Inc. |
Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
US10787454B2
(en)
|
2016-04-06 |
2020-09-29 |
BIAL—BioTech Investments, Inc. |
Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
WO2017192841A1
(en)
|
2016-05-04 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
EP3452480A4
(en)
|
2016-05-05 |
2019-11-06 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED PYRROLO [1,2-] TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
BR112018072552A8
(pt)
|
2016-05-05 |
2023-03-14 |
Lysosomal Therapeutics Inc |
Compostos de imidazo [1,2-b]piridazinas e imidazo [1,5-b] piridazinas substituídas, composição farmacêutica que os compreende e seu uso no tratamento de distúrbios médicos
|
|
US11345698B2
(en)
|
2016-05-05 |
2022-05-31 |
Bial—R&D Investments, S.A. |
Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders
|
|
EP3728265A1
(en)
|
2017-12-21 |
2020-10-28 |
BIAL - BioTech Investments, Inc. |
Crystalline substituted cyclohexyl pyrazolo[1,5-a]pyrimidinyl carboxamide compound and therapeutic uses thereof
|